OMICS Technologies For Predictive Modeling of Infectious Diseases Program

by: Michael Saunders

The National Institute of Health, more commonly referred to as NIH, is a federal government agency operating within the United States Department of Health and Human Services that is primarily responsible for supporting the country's biomedical and health-related research studies.

The grants and initiatives of the NIH are all geared towards the successful realization of its primary agency mission which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a partnership with the National Institute of Allergy and Infectious Diseases (NIAID) in an attempt to establish the OMICS Technologies For Predictive Modeling of Infectious Diseases Program.

The program is specifically designed to aid in the development and validation of predictive models of infectious disease initiation, progression and outcomes while employing integrated datasets generated from a combination of "omics" technologies.

OMICS technologies refer to the process involving rapid and accurate measurements tens and hundreds of thousands of data points (i.e., DNA sequences, gene expression levels) in a short period of time.

At present, there four major types of "omics" technologies that are being used to gather data, these include genomics, transcriptomics, proteomics, metabolomics.

  (continued...)

OMICS Technologies For Predictive Modeling of Infectious Diseases Program
  Page 2

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---

Exploratory Clinical Trials for Small Business Grant Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) in order to establish the Exploratory Clinical Trials for Small Business Grant Program wherein they aim to establish a vehicle for Small Business Concerns (SBCs) in the process of submitting Small Business Technology Transfer (STTR) grant applications for exploratory clinical trials directly to the NIND

---

HIV Innovations for Improved Patient Outcomes for Priority Populations Program
The United States Agency for International Development in South Africa has recently established the HIV Innovations for Improved Patient Outcomes for Priority Populations Program wherein it intends to solicit applications coming from local organizations which are interested in heading the implementation of a five-year plan centered on the program in focus.

---